Assets, Current in USD of Achilles Therapeutics plc from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Achilles Therapeutics plc quarterly Assets, Current history and change rate from Q4 2020 to Q2 2024.
  • Achilles Therapeutics plc Assets, Current for the quarter ending 30 Jun 2024 was $118M, a 32.8% decline year-over-year.
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Change (%)

Achilles Therapeutics plc Quarterly Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $118M -$57.4M -32.8% 30 Jun 2024 6-K 14 Aug 2024
Q4 2023 $146M -$50.9M -25.9% 31 Dec 2023 6-K 14 Aug 2024
Q2 2023 $175M 30 Jun 2023 6-K 04 Aug 2023
Q4 2022 $197M -$88.2M -31% 31 Dec 2022 20-F 04 Apr 2024
Q4 2021 $285M +$97M +51.6% 31 Dec 2021 20-F 07 Mar 2023
Q4 2020 $188M 31 Dec 2020 20-F 01 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.